Señales en vivo de CDX.AX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 01:59):

CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific...

Stats
Volumen de hoy	1.92M
Volumen promedio	351 011
Capitalización de mercado	12.21M
EPS	$0 ( 2024-02-28 )
Próxima fecha de ganancias	( $0 ) 2024-06-03
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.980
ATR14	$0.00100 (1.69%)

Cardiex Ltd Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cardiex Ltd Finanzas

Annual	2023
Ingresos:	$4.60M
Beneficio Bruto:	$3.70M (80.33 %)
EPS:	$-0.150

FY	2023
Ingresos:	$4.60M
Beneficio Bruto:	$3.70M (80.33 %)
EPS:	$-0.150

FY	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$0

FY	2022
Ingresos:	$4.07M
Beneficio Bruto:	$3.13M (76.85 %)
EPS:	$-0.0989

Financial Reports:

No articles found.

Cardiex Ltd

CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company undertakes contracts with pharmaceutical companies for the use of SphygmoCor XCEL devices; provides lab and data management services for clinical trials comprising end-to-end service that delivers clean datasets to study sponsors. It also develops home vascular health solutions, remote patient monitoring, decentralized clinical trials and solutions wearables, and medical health apps under the CONNEQT name, as well as CONNEQT Pulse device, a home-based heart health vital signs monitoring system, that measures central blood pressure, arterial waveforms, and various other proprietary arterial health parameters through its SphygmoCor technology. The company serves hospitals, clinics, research institutions and pharmaceutical companies. It has strategic collaboration agreement with LifeQ, Inc for wearable devices. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.